[go: up one dir, main page]

PL337003A1 - Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs - Google Patents

Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs

Info

Publication number
PL337003A1
PL337003A1 PL98337003A PL33700398A PL337003A1 PL 337003 A1 PL337003 A1 PL 337003A1 PL 98337003 A PL98337003 A PL 98337003A PL 33700398 A PL33700398 A PL 33700398A PL 337003 A1 PL337003 A1 PL 337003A1
Authority
PL
Poland
Prior art keywords
caprophen
cox
dogs
selectively acting
inflammatory states
Prior art date
Application number
PL98337003A
Other languages
English (en)
Inventor
Krystin Marie Lundy
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL337003A1 publication Critical patent/PL337003A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
PL98337003A 1997-05-05 1998-05-01 Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs PL337003A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (en) 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs

Publications (1)

Publication Number Publication Date
PL337003A1 true PL337003A1 (en) 2000-07-31

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98337003A PL337003A1 (en) 1997-05-05 1998-05-01 Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs

Country Status (32)

Country Link
EP (1) EP0988034A1 (xx)
JP (1) JP2000513020A (xx)
KR (2) KR20010012300A (xx)
CN (1) CN1255059A (xx)
AP (1) AP9801234A0 (xx)
AR (2) AR011726A1 (xx)
AU (1) AU6932198A (xx)
BG (1) BG103852A (xx)
BR (1) BR9808720A (xx)
CA (1) CA2288759A1 (xx)
DZ (1) DZ2479A1 (xx)
EA (1) EA003696B1 (xx)
GT (1) GT199800063A (xx)
HR (1) HRP980244A2 (xx)
HU (1) HUP0001286A3 (xx)
ID (1) ID21311A (xx)
IL (1) IL132570A0 (xx)
IS (1) IS5220A (xx)
MA (1) MA26491A1 (xx)
NO (1) NO995389L (xx)
NZ (1) NZ500183A (xx)
OA (1) OA11213A (xx)
PA (1) PA8450601A1 (xx)
PE (1) PE72599A1 (xx)
PL (1) PL337003A1 (xx)
SK (1) SK148199A3 (xx)
TN (1) TNSN98059A1 (xx)
TW (1) TW590773B (xx)
UY (1) UY24989A1 (xx)
WO (1) WO1998050033A1 (xx)
YU (1) YU55899A (xx)
ZA (1) ZA983722B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
EP1123091A1 (en) * 1998-10-23 2001-08-16 Merck Frosst Canada & Co. Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
EP1637137A3 (en) * 1999-03-10 2006-07-05 G.D. Searle LLC Method and composition for administering a cyclooxygenase-2 inhibitor to animals
WO2001034204A1 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US20020016342A1 (en) * 2000-05-15 2002-02-07 Edward Scolnick Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor
US6924303B2 (en) 2000-06-13 2005-08-02 Wyeth Analgesic and anti-inflammatory compositions containing COX-2 inhibitors
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
CA2422803A1 (en) 2000-08-07 2002-02-14 Vanderbilt University Detection of cox-2 activity and anandamide metabolites
US20040209959A1 (en) * 2001-07-16 2004-10-21 Edward Hogestatt Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
PL2266585T3 (pl) 2003-05-07 2013-10-31 Osteologix As Rozpuszczalne w wodzie sole stronktu do stosowania w leczeniu chorób chrząstki i/lub kości
EP1651210A1 (en) * 2003-07-31 2006-05-03 Pharmacia & Upjohn Company LLC Dispersible formulation of an anti-inflammatory agent
US20080269310A1 (en) * 2005-05-20 2008-10-30 Adrian Paul Foster Synergistic Combinations
CA2683415C (en) 2007-04-04 2020-12-08 Sigmoid Pharma Limited An oral pharmaceutical composition
WO2008132707A1 (en) 2007-04-26 2008-11-06 Sigmoid Pharma Limited Manufacture of multiple minicapsules
JP5640079B2 (ja) 2009-05-18 2014-12-10 シグモイド・ファーマ・リミテッドＳｉｇｍｏｉｄ Ｐｈａｒｍａ Ｌｉｍｉｔｅｄ 油滴含有組成物
BR112012002963A2 (pt) 2009-08-12 2017-10-24 Sigmoid Pharma Ltd composições imunomoduladoras compreendendo uma matriz de polímero e uma fase oleosa
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
ES2907285T3 (es) * 2014-03-06 2022-04-22 Elanco Animal Health Incorporated Composiciones de grapiprant y procedimientos de uso de las mismas
EA036036B1 (ru) 2014-11-07 2020-09-16 Сигмойд Фарма Лимитед Композиции, содержащие циклоспорин
EP3242557A4 (en) * 2015-01-09 2018-09-05 Jaguar Health, Inc. Methods of treating diarrhea in companion animals
JP2023520367A (ja) * 2020-03-25 2023-05-17 エスアールアイ インターナショナル リポキシゲナーゼ阻害剤
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
EP0988034A1 (en) 2000-03-29
TW590773B (en) 2004-06-11
EA003696B1 (ru) 2003-08-28
EA199900895A1 (ru) 2000-06-26
OA11213A (en) 2003-07-14
BG103852A (en) 2000-06-30
MA26491A1 (fr) 2004-12-20
WO1998050033A1 (en) 1998-11-12
IL132570A0 (en) 2001-03-19
CA2288759A1 (en) 1998-11-12
PE72599A1 (es) 1999-08-12
AR039628A2 (es) 2005-03-02
UY24989A1 (es) 2001-10-25
HRP980244A2 (en) 1999-02-28
NZ500183A (en) 2002-04-26
AR011726A1 (es) 2000-08-30
SK148199A3 (en) 2001-09-11
AU6932198A (en) 1998-11-27
ID21311A (id) 1999-05-20
ZA983722B (en) 1999-11-04
TNSN98059A1 (fr) 2005-03-15
AP9801234A0 (en) 1999-11-04
BR9808720A (pt) 2000-07-11
CN1255059A (zh) 2000-05-31
IS5220A (is) 1999-10-19
PA8450601A1 (es) 2000-05-24
KR20040004406A (ko) 2004-01-13
KR20010012300A (ko) 2001-02-15
HUP0001286A3 (en) 2000-12-28
DZ2479A1 (fr) 2003-02-01
JP2000513020A (ja) 2000-10-03
NO995389D0 (no) 1999-11-04
NO995389L (no) 2000-01-04
HUP0001286A2 (hu) 2000-11-28
YU55899A (sh) 2003-08-29
GT199800063A (es) 1999-10-26

Similar Documents

Publication Publication Date Title
PL337003A1 (en) Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs
PL336758A1 (en) Substituted imidazoles useful in treating inflammatory states
HUP0004484A3 (en) Desaturase genes and their use
ATE318746T1 (de) Lasttragende und steuerbare einheit
DE69832027D1 (de) Integriertes kraft-und steuerungssystem
DE69836460D1 (de) Übertragungsgerät und Lastverteilungsübertragungsverfahren im Übertragungsgerät
PL337665A1 (en) (s) 2-methylamine-2-phenyl-n-butyl-3,4,5-trimethoxybezoate and application thereof in treating long-lasting pains
GB9704162D0 (en) Assay methods and means
GB2328299B (en) Data-processing device and method
AU5871898A (en) Microparticles and their use in cancer treatment
AU7368198A (en) Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals
DE69628756D1 (de) Kombinierte longitudinale und transversale Spurnachführung
PL339804A1 (en) Application of thiazolydine diones in treating hyperglycaemia
GB9625666D0 (en) Improvements in construction and control
ZA972543B (en) Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
GB9705561D0 (en) Localized object and domestic cat locateing device
AU7334398A (en) Transgenic animal with controllable hyperproliferation and inflammation phenotype in the skin
BR7601188U (pt) Disposiçao introduzida em carteira
BR9705337A (pt) Aperfeiçoamento introduzidos em duchas chuveiros eletricos e outros
GB9726490D0 (en) Hydraulic power arrangement and method
GB9603168D0 (en) Microorganisms and their use in treating silage
BR7600753U (pt) Disposição construtiva em picador liquidificador - sistema de acionamento e arraste
NL1005646A1 (nl) Werkwijze en toestel voor het reduceren van de stroomopname in een plasma-geadresseerde structuur.
AU1374599A (en) Materials and methods for preventing cellular injury in humans and animals
GB9818187D0 (en) Improvements in and relating to access control